Label: BACLOFEN- baclofen 20mg tablet

  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated February 8, 2021

If you are a consumer or patient please visit this version.

  • Dosage and Administration Section

    DOSAGE AND ADMINISTRATION

    The determination of optimal dosage requires individual titration. Start therapy at a low dosage and increase gradually until optimum effect is achieved (usually between 40 to 80 mg daily).

    The following dosage titration schedule is suggested:

    5 mg t.i.d. for 3 days
    10 mg t.i.d. for 3 days
    15 mg t.i.d. for 3 days
    20 mg t.i.d. for 3 days

    Thereafter additional increases may be necessary but the total daily dose should not exceed a maximum of 80 mg daily (20 mg q.i.d.).

    The lowest dose compatible with an optimal response is recommended. If benefits are not evident after a reasonable trial period, patients should be slowly withdrawn from the drug (see WARNINGS, ABRUPT DRUG WITHDRAWAL).

  • Indications and Usage Section

    INDICATIONS AND USAGE

    Baclofen tablets USP are useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity.

    Patients should have reversible spasticity so that baclofen treatment will aid in restoring residual function. Baclofen tablets USP may also be of some value in patients with spinal cord injuries and other spinal cord diseases.

    Baclofen tablets USP are not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders.

    The efficacy of baclofen in stroke, cerebral palsy, and Parkinson's disease has not been established and, therefore, it is not recommended for these conditions.

  • Principal Display Panel

    Baclofen 20mg

  • INGREDIENTS AND APPEARANCE
    BACLOFEN 
    baclofen 20mg tablet
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:80425-0112(NDC:0527-1337)
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    BACLOFEN (UNII: H789N3FKE8) (BACLOFEN - UNII:H789N3FKE8) BACLOFEN20 mg
    Product Characteristics
    ColorwhiteScore2 pieces
    ShapeROUNDSize10mm
    FlavorImprint Code LCI;1337
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:80425-0112-130 in 1 BOTTLE; Type 0: Not a Combination Product12/20/2005
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA07724112/20/2005
    Labeler - Advanced Rx Pharmacy of Tennessee, LLC (117023142)
    Establishment
    NameAddressID/FEIBusiness Operations
    Advanced Rx Pharmacy of Tennessee, LLC117023142repack(80425-0112)